Tag: medicines

Federal Court Ruling Upholds Data Protection Period for Research-Based, Innovative Drug Companies

The period of data protection allocated to research-based, innovative drug companies is a hotly debated topic in the pharmaceutical industry and beyond. This period of protection

August 7, 2009 2 Comments

Federal Court of Appeal’s Decision Interpreting Section 8 of the Patented Medicines (Notice of Compliance) Regulations Leads to Mixed Results

The Federal Court of Appeal has recently released its first decision interpreting Section 8 of the Patented Medicines (Notice of Compliance) Regulations [PM(NOC)]. The PM(NOC)

June 16, 2009 No Comments

Tag: medicines

Federal Court Ruling Upholds Data Protection Period for Research-Based, Innovative Drug Companies

Federal Court of Appeal’s Decision Interpreting Section 8 of the Patented Medicines (Notice of Compliance) Regulations Leads to Mixed Results

Search

Categories

Newsletter